Tumor-Agnostic Precision Medicine from the AACR GENIE Database: Clinical Implications

Biomarker-driven cancer therapy has revolutionized precision oncology. With a better understanding of tumor biology, tissue-agnostic targets have been characterized and explored, which ultimately led to therapeutics with pan-cancer efficacy. To date, five molecular biomarkers have obtained FDA tissu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical cancer research 2023-08, Vol.29 (15), p.2753-2760
Hauptverfasser: Gouda, Mohamed A, Nelson, Blessie E, Buschhorn, Lars, Wahida, Adam, Subbiah, Vivek
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!